CBPO [China Biologic Products] S-3: (Original Filing)

[Registration No. 333- ____________________________ FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of incorporation (I.R.S. Employer or organization) Identification No.) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China +8610-6598-3111 ____________________________ Corporation Service Company 2711 Centerville Road, Suite 400 Wilmington,] [Letter of Undertaking To: Madrone Partners, LP June 6, 2012 Dear Sirs: Holder Company Very truly yours, China Biologic Products, Inc. Ming Yang Interim Chief Financial Officer & Compliance Officer] [Letter of Undertaking To: Essence International Investment Limited June 6, 2012 Dear Sirs: Holder Company Very truly yours, China Biologic Products, Inc. Ming Yang Interim Chief Financial Officer & Compliance Officer] [July 11, 2012 China Biologic Products, Inc. Re: Registration Statement on Form S-3 Ladies and Gentlemen: Based upon the foregoing, and subject to the qualifications set forth below, we are of the opinion that the Shares are validly issued, fully paid and non-assessable. * * * Very truly yours, WILSON SONSINI GOODRICH & ROSATI] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the use of our reports dated March 12, 2012, with respect to the consolidated balance sheets of China Biologic Products, Inc. as of December 31, 2011 and 2010, and the related consolidated statements of comprehensive income, changes in equity, and cash flows for each of the] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of We consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 23, 2010, except for the effects on the consolidated financial statements of the restatement described in Note 2, as to which the date is March 31, 2011, with]

DQ [DAQO NEW ENERGY] 6-K: (Original Filing)

[Daqo New Energy Announces Share Repurchase Program CHONGQING, China, July 9, 2012 – Daqo New Energy Corp. (NYSE: DQ) (“Daqo New Energy” or the “Company”), a leading polysilicon manufacturer based in China, today announced that its board of directors has approved a share repurchase program, effective immediately. The board of directors has authorized Daqo New Energy to repurchase up to]

By | 2016-03-02T08:04:53+00:00 July 10th, 2012|Categories: Chinese Stocks, DQ, SEC Original|Tags: , , , , , |0 Comments

LEDS [SemiLEDs] 8-K: (Original Filing)

[SemiLEDs Reports Third Quarter of Fiscal Year 2012 Financial Results Hsinchu, Taiwan (July 10, 2012) — SemiLEDs Corporation (NASDAQ: LEDS), “SemiLEDs” or the “Company,” a developer and manufacturer of LED chips and LED components, today announced its financial results for the third quarter of fiscal year 2012, ended May 31, 2012. Revenue for the third quarter of fiscal 2012 was] []

By | 2016-04-03T05:45:02+00:00 July 10th, 2012|Categories: Chinese Stocks, LEDS, SEC Original|Tags: , , , , , |0 Comments

LFC [CHINA LIFE INSURANCE CO] 6-K: (Original Filing)

[CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the People’s Republic of China with limited liability) (the “Company”) (Stock Code: 2628) ANNOUNCEMENT OF THE RESOLUTIONS PASSED AT THE FIRST EXTRAORDINARY GENERAL MEETING 2012 AND ELECTION OF MEMBERS OF THE FOURTH SESSION OF THE BOARD AND THE SUPERVISORY COMMITTEE OF THE COMPANY Board Company EGM The board] [Description 99.1 Announcement, dated July 10, 2012]

By | 2016-03-28T06:00:32+00:00 July 10th, 2012|Categories: Chinese Stocks, LFC, SEC Original|Tags: , , , , , |0 Comments

SEED [Origin Agritech] 6-K: (Original Filing)

[Origin Agritech Provides Update on Corn Seed R&D Programs Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”) BEIJING--(BUSINESS WIRE)--July 10, 2012-- GM Corn Seed Pipeline Genetically modified seed products in China must initially undergo a five-stage approval process consisting of Phase 1 - Laboratory Research, Phase 2 - Intermediate Test, Phase 3 - Environment Release Test, Phase 4 -] [Origin’s GM Corn Seed Pipeline Traits Phytase1 Glyphosate Tolerance2 Bt3 Glyphosate + Bt4 Nitrogen Use Efficiency Drought Tolerance PHASE1 PHASE2 PHASE3 PHASE4 PHASE5 Corn Hybrid + GMO Commercialization Laboratory Research Intermediate Test Environment Release Test Production Test Safety Certificate Variety Production Test Variety Approval Progress from 2011 to 2012 Notes: The variety production test of two corn hybrids with phytase]

By | 2016-03-10T18:42:20+00:00 July 10th, 2012|Categories: Chinese Stocks, SEC Original, SEED|Tags: , , , , , |0 Comments
Skip to toolbar